Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors
Page 1 of 1
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors
Jon Moulton Thu Feb 09, 2017 10:16 am
Doulatov S, Vo LT, Macari ER, Wahlster L, Kinney MA, Taylor AM, Barragan J, Gupta M, McGrath K, Lee H-Y, Humphries JM, DeVine A, Narla A, Alter BP, Beggs AH, Agarwal S, Ebert BL, Gazda HT, Lodish HF, Sieff CA, Schlaeger TM, Zon LI, Daley GQ. Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Science Transl Med. 2017;9(376). doi:10.1126/scitranslmed.aah5645
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Assessment of hematopoietic failure due to Rpl11 deficiency in a zebrafish model of Diamond-Blackfan anemia by deep sequencing
» L-Leucine improves anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q)MDS by activating the mTOR pathway
» The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia
» RAP-011 improves erythropoiesis in zebrafish model of Diamond-Blackfan anemia through antagonizing lefty1
» Transcriptome analysis of Rpl11-deficient zebrafish model of Diamond-Blackfan Anemia
» L-Leucine improves anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q)MDS by activating the mTOR pathway
» The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia
» RAP-011 improves erythropoiesis in zebrafish model of Diamond-Blackfan anemia through antagonizing lefty1
» Transcriptome analysis of Rpl11-deficient zebrafish model of Diamond-Blackfan Anemia
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum